Clinical trial
A Phase II/III Pivotal Trial Evaluating the Safety, Pharmacokinetic Properties and Efficacy of a Plasma-Derived Anti-thrombin III Concentrate With Administration in Surgery, Pregnancy and Thromboembolic or Thrombotic Events
NCT00319228 is registered in ClinicalTrials.gov with Instituto Grifols, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II/III Pivotal Trial Evaluating the Safety, Pharmacokinetic Properties and Efficacy of a Plasma-Derived Anti-thrombin III Concentrate With Administration in Surgery, Pregnancy and Thromboembolic or Thrombotic Events
- Lead sponsor
- Instituto Grifols, S.A.
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- April 15, 2008
- Completion date
- December 16, 2011
- Enrollment
- 3 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.